HIV testing, staging, and evaluation

Infect Dis Clin North Am. 2014 Sep;28(3):339-53. doi: 10.1016/j.idc.2014.06.002.

Abstract

HIV testing and incidence are stable, but trends for certain populations are concerning. Primary prevention must be reinvigorated and target vulnerable populations. Science and policy have progressed to improve the accuracy, speed, privacy, and affordability of HIV testing. More potent and much better tolerated HIV treatments and a multidisciplinary approach to care have increased adherence and viral suppression. Changes to health care law in the United States seek to expand the affordability and access of improved HIV diagnostics and treatment. Continued challenges include improving long-term outcomes in people on lifetime regimens, reducing comorbidities associated with those regimens, and preventing further transmission.

Keywords: HIV epidemiology; HIV surveillance.

Publication types

  • Review

MeSH terms

  • Anti-Retroviral Agents / therapeutic use*
  • HIV Infections / complications
  • HIV Infections / diagnosis*
  • HIV Infections / drug therapy*
  • HIV Infections / prevention & control
  • Health Policy / trends
  • Health Services Accessibility*
  • Humans
  • United States

Substances

  • Anti-Retroviral Agents